Table 1.

Effect of CD31 Peptide on the Secondary MLR

RestimulatorPrimed Balb/c Cells in the Absence of CD31 PeptidePrimed Balb/c Cells in the Presence of CD31 Peptide
Culture Days and cpm34567Culture Days and cpm34567
22
None 1,251 779 549 462 388 307 1,955 1,701 1,288 1,021 557 560 
C57BL/6 207,504 192,084 97,668 54,524 63,116 63,116 2,001 1,904 1,474 1,280 760 572 
CBA 37,294 34,634 48,541 40,068 54,919 47,958 2,560 2,130 1,740 1,286 685 655 
C57BL/6 + IL-2  —   —   —   —   —   —  2,608 3,920 1,626 1,208 1,328 1,021 
ConA 76,783  —   —   —   —   —  26,464  —   —   —   —   —  
RestimulatorPrimed Balb/c Cells in the Absence of CD31 PeptidePrimed Balb/c Cells in the Presence of CD31 Peptide
Culture Days and cpm34567Culture Days and cpm34567
22
None 1,251 779 549 462 388 307 1,955 1,701 1,288 1,021 557 560 
C57BL/6 207,504 192,084 97,668 54,524 63,116 63,116 2,001 1,904 1,474 1,280 760 572 
CBA 37,294 34,634 48,541 40,068 54,919 47,958 2,560 2,130 1,740 1,286 685 655 
C57BL/6 + IL-2  —   —   —   —   —   —  2,608 3,920 1,626 1,208 1,328 1,021 
ConA 76,783  —   —   —   —   —  26,464  —   —   —   —   —  

A total of 5 × 106 BALB/c spleen cells was primed with 5 × 106 C57BL/6 irradiated spleen cells in absence of peptide (left) or presence of CD31 peptide (right) or control peptide (20 μg/mL). Primed cells were restimulated with fresh stimulator C57BL/6 cells or CBA cells or ConA 2 μg/mL and also IL-2 200 IU per well was added to the additional wells, where primed cells were restimulated with irradiated BALB/c stimulator. Results are expressed as cpm from triplicate cultures. Typical standard deviations were <20% of the mean. Cells primed in the presence of control peptide showed the similar results to cells primed without peptide (data not shown).

or Create an Account

Close Modal
Close Modal